Skip to main content
Clinical Trials/JPRN-jRCT1030220111
JPRN-jRCT1030220111
Recruiting
未知

Multicenter prospective observational study to identify plasm beta cell-specific peptides

Miyatsuka Takeshi0 sites300 target enrollmentJune 4, 2022
ConditionsType 1 diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
Miyatsuka Takeshi
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Miyatsuka Takeshi

Eligibility Criteria

Inclusion Criteria

  • More than 18 years old patients with a diagnosis of type 1 diabetes and type 1 diabetes caused by immune checkpoint inhibitors from the date of approval by the hospital director to March 31, 2025, have been started treatment at the Department of Endocrinology and Metabolism, Kitasato University Hospital or the Department of Endocrinology and Metabolism, Kitasato University Medical Center, understand the purpose of this study and are given consent. More than 18 years old normal glucose\-tolerant subjects (volunteers) understand the purpose of the study and are given their consent. Volunteers will be recruited by posting posters on the bulletin board in the School of Medicine.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials